Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2021-05-18 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
2021- 泰林生物：2020年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2020 annual dividend distribution plan approved at the 2020 Annual General Meeting. It details the dividend amount, record date, ex-dividend date, eligible shareholders, and payment method. It does not contain financial statements or detailed financial performance data. The document is short (1446 characters) and serves as a formal notice of dividend distribution rather than a full report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2021-05-18 Chinese
泰林生物2020年年度股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2020 Annual General Meeting (AGM) of Zhejiang Tailin Biotechnology Co., Ltd. It details the legality of the AGM procedures, qualifications of attendees, and the validity of resolutions passed, including approval of the 2020 annual report and other related matters. The document is not the annual report itself but a legal opinion on the AGM and its proceedings. It includes voting results and confirms the legality of the meeting and resolutions. This type of document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting outcomes and validates the AGM process. The document length is under 5,000 characters, but it contains detailed voting results and legal validation, not just an announcement of a report publication, so it is not RPA or RNS. Therefore, the best classification is DVA with high confidence.
2021-05-17 Chinese
2020年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as an announcement of the 2020 Annual General Meeting (AGM) resolutions of Zhejiang Tailin Biotechnology Co., Ltd. It details the meeting date, attendance, voting results on various proposals including the 2020 annual report, board and supervisory reports, profit distribution, financial statements, auditor appointment, remuneration plans, and special reports on fund usage. The document also includes legal opinions confirming the legality and validity of the meeting and resolutions. The content is focused on the voting results and resolutions passed at the AGM rather than the full annual report or financial statements themselves. The document length is relatively short (3139 characters) and it serves as an official announcement of the AGM resolutions and voting outcomes. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-05-17 Chinese
关于2020年年度股东大会更正补充公告
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a correction and supplement announcement related to the 2020 Annual General Meeting (AGM) of Zhejiang Tailin Biotechnology Co., Ltd. It specifically addresses corrections to the proposals and voting options for the AGM. The document does not contain the full AGM materials or presentations but rather an announcement correcting previously disclosed AGM information. The document length is short (1307 characters), and it serves as an announcement rather than the AGM report itself. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly AGM Information (AGM-R). However, since it is a correction to the AGM notice and relates to voting proposals, the best fit is Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-05-13 Chinese
关于召开2020年年度股东大会的提示性通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2020 Annual General Meeting (AGM) of Zhejiang Tailin Biotechnology Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items to be discussed and voted on, registration details, and attachments such as proxy forms and attendance lists. The document does not contain the actual annual report or financial statements but rather serves as a notification and instructions for shareholders regarding the AGM. The presence of agenda items like the annual report and financial statements indicates the meeting's purpose but does not constitute the report itself. The document length is about 4759 characters, which is consistent with a detailed AGM notice. Therefore, the appropriate classification is AGM Information (AGM-R).
2021-05-13 Chinese
补充法律意见书（二）（更新2020年年报）
Capital/Financing Update Classification · 95% confidence The document is a detailed legal opinion letter from Shanghai Jintiancheng Law Firm regarding Zhejiang Tailin Biotechnology Co., Ltd.'s issuance of convertible bonds to unspecified investors. It references prior legal opinion letters, lawyer work reports, audit reports, and compliance with securities laws and regulations. The content includes legal assessments, shareholder information, business descriptions, related party transactions, and intellectual property updates. The document is lengthy (15,000 characters) and contains substantive legal and financial information related to a capital issuance. It is not a simple announcement or certification but a comprehensive legal opinion report supporting a financing activity. Therefore, the document fits best under the category of Capital/Financing Update (CAP), as it provides detailed legal opinions and updates related to the company's convertible bond issuance.
2021-04-29 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.